Expression of pEGFR and pAKT as response-predictive biomarkers for RAS wild-type patients to anti-EGFR monoclonal antibodies in metastatic colorectal cancers

BACKGROUND: RAS wild-type (RAS(w/t)) tumours have been associated with better outcomes in patients with metastatic colorectal cancer (mCRC) treated with anti-EGFR monoclonal antibodies (mAb). We investigated the expression of EGFR downstream proteins under their active phosphorylated forms as potent...

Descripción completa

Detalles Bibliográficos
Autores principales: Harlé, A, Salleron, J, Perkins, G, Pilati, C, Blons, H, Laurent-Puig, P, Merlin, J L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4647679/
https://www.ncbi.nlm.nih.gov/pubmed/26171935
http://dx.doi.org/10.1038/bjc.2015.250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4647679/
https://www.ncbi.nlm.nih.gov/pubmed/26171935
http://dx.doi.org/10.1038/bjc.2015.250

Ejemplares similares